Skip to content
Search

Latest Stories

Research shows middle-age Covid-19 mortality risk

Middle-aged people, and not just the elderly, have a dramatically higher risk of dying or developing serious illness from Covid-19, new research from Britain showed Tuesday (31).

The findings came in a new comprehensive analysis of virus cases in mainland China.


Researchers from Britain analysed more than 3,600 confirmed Covid-19 cases as well as data from hundreds of passengers repatriated from the outbreak city of Wuhan.

They found that age was a key determining factor in serious infections, with nearly one in five over-80s requiring hospitalisation, compared to around 1 percent among people under 30.

Taking into account estimates of the number of cases that may not have been clinically confirmed - that is, mild or asymptomatic infections - the data showed the hospitalisation rate of patients in their fifties was 8.2 per cent.

The study, published in The Lancet Infectious Diseases journal, estimated that the mortality rate from confirmed Covid-19 cases in mainland China was 1.38 per cent.

If unconfirmed cases were taken into account, the death rate dropped to 0.66 per cent.

The authors of the research said that while this was significantly lower than previous estimates, Covid-19 is still several times deadlier than previous pandemic viruses, such as H1N1.

"Our estimates can be applied to any country to inform decisions around the best containment policies for Covid-19," said Azra Ghani, a study co-author from Imperial College London.

"There might be outlying cases that get a lot of media attention, but our analysis very clearly shows that at aged 50 and over, hospitalisation is much more likely than in those under 50, and a greater proportion of cases are likely to be fatal."

Billions of people have been confined to their homes around the world as governments desperately try to stop the spread of the novel coronavirus.

As of 1900 GMT Monday (30) the virus had killed 36,374 people out of 757,940 cases globally.

That would mean 4.8 per cent of all confirmed Covid-19 infections have proven deadly.

But experts stress that without widespread testing it is impossible to know how many people may have become infected and recovered.

This means the true mortality rate is likely much lower, in line with The Lancet study and previous research from China.

The Lancet study showed that 18.4 per cent of patients in their 80s were hospitalised in China.

This compared to 4.3 percent for 40 to 49-year-olds and roughly 1 percent for people in their 20s.

According to their modelling, the authors estimate that 50-80 percent of the global population could contract Covid-19 but that came with several caveats, as modelling can't account for behavioural changes such as hand washing and social distancing.

Devi Sridhar, professor and chair of Global Public Health, at the University of Edinburgh's Medical School, said that the assumption that most people would become infected was leading governments, including in Britain, to abandon measures that could help slow the pandemic.

She tweeted on Tuesday that the models "resulted in the UK giving up on containment too early & assuming everyone will get it.

"Planning & preparing for unprecedented testing & using big data/apps for tracing were taken off the table. In my view, we went down the wrong path," she said.

More For You

AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Numark launches new digital consultation platform to support independent prescribers

Harry McQuillan, Chairman of Numark

Numark launches DigiPharma to empower independent prescribers

Numark has launched a new digital consultation platform, called DigiPharma, designed to support both current and future independent prescribers (IPs) in making full use of their qualifications.

The revolutionary cloud-based prescribing recording platform is now available exclusively to Numark members.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less